arrow
返回

Modelling iterative compound optimisation using a self-avoiding walk

delete2009-02-01
delete8
PRE
AI
J
John Delaney *
DOI:10.1016/j.drudis.2008.10.007delete
delete原文链接
delete原文求助
delete分享
delete收藏
摘要

摘要

En 中文
The optimisation phase is a crucial step in the process of drug development, yet the mechanics of the projects that make it up are poorly understood. Weak documentation of failed projects makes statistical analysis of the factors affecting project performance challenging, so a better approach may be the development of an underlying theory of how projects work. We present a model based on a modified random walk in a relevant chemical space and use it to produce simulations of projects and portfolios of projects. Simulation is used to explore parameters that might affect the performance of a project and shows that they fall into two groups - target and process - that affect the overall performance in distinct ways.
Keyword:
DRUG DEVELOPMENT
INNOVATION
QSAR
END
AI总结

AI总结

对已上传原文的论文进行重点信息的提取,主要内容包括:简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。

期刊

Drug Discovery Today 封面图
Drug Discovery Today
IF:
7.5
论文数:
6.4K
被引数:
2.3W

机构

暂无机构信息
引用论文

引用论文

Mobility management for IoT: a survey
err2016-07-11
err0
errOAAI
errSafwan M. Ghaleb; Shamala Subramaniam; Zuriati Ahmed Zukarnain; Abdullah Muhammed
err分享
err收藏
Chemical space travel
err2007-04-30
err57
PREAI
errvan Deursen, Ruud; Reymond, Jean-Louis
err分享
err收藏
Fractionation ofPneumocystis carinii developmental stages by counterflow centrifugal elutriation and sequential filtrations
err1994-01-01
err0
PREAI
errJ. A. De Stefano; J. M. Foy; D. W. Sullivan; S. M. Dawes; M. T. Cushion; G. F. Babcock; R. G. Sleight; H. van Halbeek; P. D. Walzer
err分享
err收藏
Molecular Differences and Similarities between Alzheimer's Disease and the 5XFAD Transgenic Mouse Model of Amyloidosis
err2013-11-21
err0
errOAAI
errChera L. Maarouf; Tyler A. Kokjohn; Charisse M. Whiteside; MiMi P. Macias; Walter M. Kalback; Marwan N. Sabbagh; Thomas G. Beach; Robert Vassar; Alex E. Roher
err分享
err收藏
Modelling and simulation in clinical drug development
err2001-08-01
err22
PREAI
errRooney, KF; Snoeck, E; Watson, PH
err分享
err收藏
err分享
err收藏
学者 查看更多内容